Peer-reviewedPublisher termsDiabetes, Obesity, and Cardiometabolic CARE
Comparative Effectiveness of Individual DPP-4 Inhibitors on Kidney Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: A Target Trial Emulation
15 affiliations
- 1Advocate Lutheran General Hospital, Park Ridge, IL
- 2Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT
- 3Department of Pharmacotherapy, Washington State University, Spokane, WA
- 4Providence Medical Research Center, Spokane, WA
- 5Department of Public Health Sciences, University of Chicago, Chicago, IL
- 6Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN
- 7Optum Labs, Eden Prairie, MN
- 8Division of Endocrinology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL
- 9Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA
- 10Department of Internal Medicine, Yale School of Medicine, New Haven, CT
- 11Department of Health Policy and Management, Yale School of Public Health, New Haven, CT
- 12Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN
- 13Knowledge and Evaluation Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, MN
- 14Division of Endocrinology, Diabetes, & Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
- 15University of Maryland Institute for Health Computing, North Bethesda, MD
Related
- Association of Non‐Cytochrome P450 3A4‐Metabolized Statins Versus Atorvastatin With Major Adverse Cardiovascular Events in Patients With Cancer Receiving Tyrosine Kinase Inhibitors: A Propensity Score–Matched Target Trial Emulation
- Real-world effectiveness of monoclonal antibody lecanemab versus acetylcholinesterase inhibitors in Alzheimer’s disease: a target trial emulation
- Comparative Effectiveness of Tricyclic Antidepressants, Serotonin–Norepinephrine Reuptake Inhibitors, and Anticonvulsants for Diabetic Painful Neuropathy: A Systematic Review and Meta-Analysis
- Comparative effectiveness of IL-12/23 and IL-23 inhibitors versus JAK inhibitors in patients with inflammatory bowel disease and hidradenitis suppurativa: a real-world propensity-matched analysis
- Long-Term Cardiovascular, Thromboembolic, and Malignancy Safety of Janus Kinase (JAK) Inhibitors in Dermatologic and Rheumatologic Populations: A Narrative Comparative Review.
BibTeX
@article{sklepinski2026comparative,
title = {{Comparative Effectiveness of Individual DPP-4 Inhibitors on Kidney Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: A Target Trial Emulation}},
author = {Stacey M. Sklepinski and Jeph Herrin and Joshua J. Neumiller and Eric C. Polley and Kavya Sindhu Swarna and Yihong Deng and Rodolfo J. Galindo and Guillermo E. Umpierrez and Joseph S. Ross and Juan P. Brito and Victor M. Montori and Mindy M. Mickelson and Rozalina G. McCoy},
journal = {Diabetes, Obesity, and Cardiometabolic CARE},
year = {2026},
month = jul,
doi = {10.2337/doc26-0025},
url = {https://doi.org/10.2337/doc26-0025},
}
RIS
TY - JOUR
TI - Comparative Effectiveness of Individual DPP-4 Inhibitors on Kidney Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: A Target Trial Emulation
AU - Stacey M. Sklepinski
AU - Jeph Herrin
AU - Joshua J. Neumiller
AU - Eric C. Polley
AU - Kavya Sindhu Swarna
AU - Yihong Deng
AU - Rodolfo J. Galindo
AU - Guillermo E. Umpierrez
AU - Joseph S. Ross
AU - Juan P. Brito
AU - Victor M. Montori
AU - Mindy M. Mickelson
AU - Rozalina G. McCoy
PY - 2026
DA - 2026/07/16
JO - Diabetes, Obesity, and Cardiometabolic CARE
DO - 10.2337/doc26-0025
UR - https://doi.org/10.2337/doc26-0025
SN - 3067-3518
SN - 3067-3534
ER -